We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+23.79%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$340M
AUM Growth
-$5.31M
Cap. Flow
-$33M
Cap. Flow %
-9.71%
Top 10 Hldgs %
23.05%
Holding
889
New
138
Increased
211
Reduced
255
Closed
64

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$10.1M
2
VALE icon
Vale
VALE
+$2.39M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.33M
4
KO icon
Coca-Cola
KO
+$2.2M
5
WFC icon
Wells Fargo
WFC
+$1.58M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.45%
2 Technology 13.37%
3 Healthcare 13.11%
4 Financials 10.95%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
301
BeOne Medicines Ltd
ONC
$33.4B
$217K 0.06%
840
+80
+11% +$22K
BKI
302
DELISTED
Black Knight, Inc. Common Stock
BKI
$215K 0.06%
2,431
+1,441
+146% +$131K
ALC icon
303
PUT
Alcon
ALC
$33.9B
$208K 0.06%
360
-1,554
-81% -$97.2K
ZM icon
304
Zoom
ZM
$27.1B
$207K 0.06%
+614
New +$274K
EHC icon
305
Encompass Health
EHC
$11B
$207K 0.06%
3,146
+1,747
+125% +$103K
AUY
306
DELISTED
Yamana Gold, Inc.
AUY
$204K 0.06%
35,657
-54,833
-61% -$308K
SBUX icon
307
Starbucks
SBUX
$121B
$203K 0.06%
1,902
+933
+96% +$89.1K
ERTH icon
308
Invesco MSCI Sustainable Future ETF
ERTH
$134M
$203K 0.06%
+2,700
New +$179K
TOL icon
309
Toll Brothers
TOL
$14B
$199K 0.06%
4,574
+2,790
+156% +$129K
UAL icon
310
United Airlines
UAL
$40.1B
$198K 0.06%
4,579
+395
+9% +$16K
XME icon
311
State Street SPDR S&P Metals & Mining ETF
XME
$3.92B
$197K 0.06%
5,900
TCOM icon
312
Trip.com Group
TCOM
$29.3B
$197K 0.06%
5,834
+453
+8% +$14.8K
HCA icon
313
HCA Healthcare
HCA
$85.7B
$195K 0.06%
1,188
+159
+15% +$23.2K
FTI icon
314
TechnipFMC
FTI
$27.5B
$195K 0.06%
27,649
+1,441
+5% +$8.47K
UFO icon
315
Procure Space ETF
UFO
$612M
$191K 0.06%
7,500
CWB icon
316
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.58B
$185K 0.05%
2,233
-117
-5% -$8.83K
RYTM icon
317
Rhythm Pharmaceuticals
RYTM
$7.25B
$184K 0.05%
6,174
AMT icon
318
American Tower
AMT
$81.3B
$182K 0.05%
810
+603
+291% +$140K
XEL icon
319
Xcel Energy
XEL
$48.8B
$181K 0.05%
2,714
+1,237
+84% +$86.2K
D icon
320
Dominion Energy
D
$61.3B
$181K 0.05%
2,402
+661
+38% +$52.5K
QDEL icon
321
QuidelOrtho
QDEL
$1.13B
$180K 0.05%
+1,002
New +$223K
KURA icon
322
Kura Oncology
KURA
$826M
$180K 0.05%
5,499
-2,085
-27% -$73.3K
RGNX icon
323
Regenxbio
RGNX
$648M
$180K 0.05%
3,958
+813
+26% +$28.4K
AREC icon
324
American Resources Corp
AREC
$196M
$178K 0.05%
+91,364
New +$154K
PLTR icon
325
Palantir
PLTR
$293B
$176K 0.05%
+7,489
New +$134K

Similar funds

Exane Derivatives's Q4 2020 Portfolio in Review

As of Q4 2020, Exane Derivatives held 889 positions worth $340M, down 1.5% from $345M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $33M in Q4 2020, closing 64 positions and reducing 255 holdings. Its most notable exit was ProShares S&P 500 Dividend Aristocrats ETF, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 8.8% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in Vale worth $3.01M.

  • Exane Derivatives's largest Q4 2020 buy was Vale: 179,430 shares worth $3.01M.
  • Exane Derivatives added most to Stellantis in Q4 2020, an estimated $10.1M increase.
  • Exane Derivatives's biggest Q4 2020 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $13.6M.
  • Exane Derivatives fully exited ProShares S&P 500 Dividend Aristocrats ETF in Q4 2020, selling an estimated $2.55M.
  • Exane Derivatives's ten largest holdings make up 23% of its $340M portfolio in Q4 2020.
  • Exane Derivatives opened 138 new positions and closed 64 in Q4 2020.
  • Exane Derivatives's portfolio value fell 1.5% quarter-over-quarter to $340M.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.